Skip to Main Content

Author Details

Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
2003
87
36
PMIDPaper TitleJournal TitlePublished Year
37474499The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37752102Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37875466Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.Nat Commun2023
37549131SliDL: A toolbox for processing whole-slide images in deep learning.PLoS One2023
37474499The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37752102Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37549131SliDL: A toolbox for processing whole-slide images in deep learning.PLoS One2023
37875466Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer.Nat Commun2023
35051729Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples.EBioMedicine2022
35843173Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning.EBioMedicine2022
35705807A pan-cancer compendium of chromosomal instability.Nature2022
35785153Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.Front Oncol2022
35398881The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.Clin Cancer Res2022
35298091Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.Mol Oncol2022
34875674Multi-omic machine learning predictor of breast cancer therapy response.Nature2022
35051729Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples.EBioMedicine2022
35843173Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning.EBioMedicine2022
35705807A pan-cancer compendium of chromosomal instability.Nature2022
35398881The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.Clin Cancer Res2022
35785153Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.Front Oncol2022
34875674Multi-omic machine learning predictor of breast cancer therapy response.Nature2022
35298091Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.Mol Oncol2022
32449758Allele-specific multi-sample copy number segmentation in ASCAT.Bioinformatics2021
32449758Allele-specific multi-sample copy number segmentation in ASCAT.Bioinformatics2021
33859411Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning.Nat Med2021
33570999FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.JCO Clin Cancer Inform2021
33315123Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer.Eur Radiol2021
34462593Reproducibility standards for machine learning in the life sciences.Nat Methods2021
33570999FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.JCO Clin Cancer Inform2021
33859411Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning.Nat Med2021
34462593Reproducibility standards for machine learning in the life sciences.Nat Methods2021
33315123Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer.Eur Radiol2021
32483290Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.Nat Genet2020
32421652Tissue-specific and interpretable sub-segmentation of whole tumour burden on CT images by unsupervised fuzzy clustering.Comput Biol Med2020
31756390Data generation and network reconstruction strategies for single cell transcriptomic profiles of CRISPR-mediated gene perturbations.Biochim Biophys Acta Gene Regul Mech2020
32483290Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.Nat Genet2020
32804543Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform.JCO Clin Cancer Inform2020
32804260Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.Insights Imaging2020
33292279Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer development.Cancer Cell Int2020
31756390Data generation and network reconstruction strategies for single cell transcriptomic profiles of CRISPR-mediated gene perturbations.Biochim Biophys Acta Gene Regul Mech2020
33292279Intestinal region-specific Wnt signalling profiles reveal interrelation between cell identity and oncogenic pathway activity in cancer development.Cancer Cell Int2020
32804543Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform.JCO Clin Cancer Inform2020
32804260Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.Insights Imaging2020
32421652Tissue-specific and interpretable sub-segmentation of whole tumour burden on CT images by unsupervised fuzzy clustering.Comput Biol Med2020
30720864Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.Int J Cancer2019
30239840Intratumoral Heterogeneity of Glioblastoma Infiltration Revealed by Joint Histogram Analysis of Diffusion Tensor Imaging.Neurosurgery2019
31510665Estimating the predictability of cancer evolution.Bioinformatics2019
31084623VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.Genome Biol2019
31026822Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging.J Neurosurg2019
31005212Low perfusion compartments in glioblastoma quantified by advanced magnetic resonance imaging and correlated with patient survival.Radiother Oncol2019
  • 1 - 50 of 174

Recommended Authors

Institute for Systems Biology
Career Start Year 2013
Number of shared co-authors 0
University of Lausanne, Switzerland Swiss Cancer Center Leman
Career Start Year 2012
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Universite de Toulouse, Inserm, CNRS, Universite Toulouse III-Paul Sabatier
Career Start Year 2009
Number of shared co-authors 1
T.J. Watson Research Center
Career Start Year 2008
Number of shared co-authors 0
University of Lausanne (UNIL)
Career Start Year 2008
Number of shared co-authors 5
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 10
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 3
Allen Institute for Cell Science
Career Start Year 2006
Number of shared co-authors 1
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 7
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 8
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2003
Number of shared co-authors 2
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital
Career Start Year 2003
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 9
Institute for Systems Biology
Career Start Year 2001
Number of shared co-authors 2
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Institute of Statistical Science
Career Start Year 2001
Number of shared co-authors 0
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 4
University of California at Santa Cruz
Career Start Year 2000
Number of shared co-authors 6
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 5
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 13
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 8
University of California San Diego
Career Start Year 1996
Number of shared co-authors 9
Columbia University
Career Start Year 1995
Number of shared co-authors 0
Technische Universitat Munchen
Career Start Year 1995
Number of shared co-authors 5
Columbia University
Career Start Year 1993
Number of shared co-authors 8
Center for Computational Biomedicine, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 2
University of California San Diego
Career Start Year 1988
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1984
Number of shared co-authors 0

Collaborators

CRUK Cambridge Institute, University of Cambridge
Co-authored papers 15
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 7
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 6
University of Regensburg
Co-authored papers 6
University of Cambridge
Co-authored papers 6
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 5
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 5
Oncode Institute
Co-authored papers 5
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 5
University of Cambridge
Co-authored papers 5
Federal University of Parana
Co-authored papers 4
ETH Zurich
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
The Francis Crick Institute
Co-authored papers 4
Lewis-Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers 4
Oncode Institute
Co-authored papers 3
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 3
CRUK Clinical Trials Unit, University of Glasgow
Co-authored papers 3
Barts Health NHS Trust
Co-authored papers 3
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 3
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 3
Temple University
Co-authored papers 3
The Medical School, The University of Sheffield
Co-authored papers 2
Cancer Research UK Cambridge Institute
Co-authored papers 2
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 2
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 2
German Cancer Research Centre DKFZ
Co-authored papers 2
Adelaide Medical School, University of Adelaide
Co-authored papers 2
Heart and Lung Research Institute, University of Cambridge
Co-authored papers 2